Dermapharm Hldg SEDermapharm Hldg SEDermapharm Hldg SE

Dermapharm Hldg SE

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.36 B‬USD
2.53USD
‪117.79 M‬USD
‪1.22 B‬USD
‪12.11 M‬
Beta (1Y)
0.53
Employees (FY)
‪3.6 K‬
Revenue / Employee (1Y)
‪339.54 K‬USD
Net income / Employee (1Y)
‪32.72 K‬USD

About Dermapharm Holding SE


CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Founded
2017
IPO date
Feb 9, 2018
Identifiers
2
ISIN DE000A2GS5D8
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.

Check out other big names from the same industry as DMPHF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DMPHF is 39.56 USD — it has decreased by −7.32% in the past 24 hours. Watch Dermapharm Hldg SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Dermapharm Hldg SE stocks are traded under the ticker DMPHF.
We've gathered analysts' opinions on Dermapharm Hldg SE future price: according to them, DMPHF price has a max estimate of 57.78 USD and a min estimate of 40.93 USD. Watch DMPHF chart and read a more detailed Dermapharm Hldg SE stock forecast: see what analysts think of Dermapharm Hldg SE and suggest that you do with its stocks.
DMPHF reached its all-time high on Nov 29, 2022 with the price of 42.68 USD, and its all-time low was 39.56 USD and was reached on Mar 27, 2025. View more price dynamics on DMPHF chart.
See other stocks reaching their highest and lowest prices.
DMPHF stock is 7.90% volatile and has beta coefficient of 0.53. Track Dermapharm Hldg SE stock price on the chart and check out the list of the most volatile stocks — is Dermapharm Hldg SE there?
Today Dermapharm Hldg SE has the market capitalization of ‪2.36 B‬, it has decreased by −7.77% over the last week.
Yes, you can track Dermapharm Hldg SE financials in yearly and quarterly reports right on TradingView.
Dermapharm Hldg SE is going to release the next earnings report on Apr 15, 2026. Keep track of upcoming events with our Earnings Calendar.
Dermapharm Hldg SE revenue for the last quarter amounts to ‪346.05 M‬ USD, despite the estimated figure of ‪354.26 M‬ USD. In the next quarter, revenue is expected to reach ‪349.89 M‬ USD.
DMPHF net income for the last quarter is ‪48.38 M‬ USD, while the quarter before that showed ‪24.61 M‬ USD of net income which accounts for 96.54% change. Track more Dermapharm Hldg SE financial stats to get the full picture.
Yes, DMPHF dividends are paid annually. The last dividend per share was 1.05 USD. As of today, Dividend Yield (TTM)% is 2.44%. Tracking Dermapharm Hldg SE dividends might help you take more informed decisions.
Dermapharm Hldg SE dividend yield was 2.31% in 2024, and payout ratio reached 42.59%. The year before the numbers were 2.08% and 75.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has ‪3.6 K‬ employees. See our rating of the largest employees — is Dermapharm Hldg SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dermapharm Hldg SE EBITDA is ‪352.30 M‬ USD, and current EBITDA margin is 25.23%. See more stats in Dermapharm Hldg SE financial statements.
Like other stocks, DMPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dermapharm Hldg SE stock right from TradingView charts — choose your broker and connect to your account.